Basic Information
| RNALocate ID: | RLID-D:11004134 |
| RNA Symbol: | hsa-miR-1226-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-1226-3p |
| RNA ID: | miRBase:MIMAT0005577 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11001635 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1226-3p | Oral squamous cell carcinoma | MNDR-E-MI-05406 |
| MNDR | hsa-miR-1226-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-05407 |
| MNDR | hsa-miR-1226-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-05408 |
| MNDR | hsa-miR-1226-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-05409 |
| MNDR | hsa-miR-1226-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-05410 |
| MNDR | hsa-miR-1226-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-05411 |
| MNDR | hsa-miR-1226-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-05412 |
| MNDR | hsa-miR-1226-3p | Her2-receptor positive breast cancer | MNDR-E-MI-05413 |
| MNDR | hsa-miR-1226-3p | Prostate cancer | MNDR-E-MI-05414 |
| MNDR | hsa-miR-1226-3p | Gastric cancer | MNDR-E-MI-05415 |
| MNDR | hsa-miR-1226-3p | Alzheimer disease | MNDR-E-MI-05416 |
| MNDR | hsa-miR-1226-3p | Cardiovascular disease | MNDR-E-MI-05417 |
| MNDR | hsa-miR-1226-3p | Parkinson disease | MNDR-E-MI-05418 |
| MNDR | hsa-miR-1226-3p | Breast cancer | MNDR-E-MI-05419 |
| MNDR | hsa-miR-1226-3p | Pancreatic cancer | MNDR-E-MI-05420 |
| MNDR | hsa-miR-1226-3p | Melanoma | MNDR-E-MI-05421 |
| MNDR | hsa-miR-1226-3p | Rectum adenocarcinoma | MNDR-E-MI-05422 |
| MNDR | hsa-miR-1226-3p | Nephroblastoma | MNDR-E-MI-05423 |
| MNDR | hsa-miR-1226-3p | Colon adenocarcinoma | MNDR-E-MI-05424 |
| MNDR | hsa-miR-1226-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-05425 |
| MNDR | hsa-miR-1226-3p | Carcinoma ductal breast | MNDR-E-MI-05426 |
| MNDR | hsa-miR-1226-3p | Glioblastoma | MNDR-E-MI-05427 |
| MNDR | hsa-miR-1226-3p | Liver cancer | MNDR-E-MI-05428 |
| MNDR | hsa-miR-1226-3p | Gastric adenocarcinoma | MNDR-E-MI-05429 |
| MNDR | hsa-miR-1226-3p | Lung squamous cell carcinoma | MNDR-E-MI-05430 |
| MNDR | hsa-miR-1226-3p | Thyroid carcinoma | MNDR-E-MI-05431 |
| MNDR | hsa-miR-1226-3p | Ovarian carcinoma | MNDR-E-MI-05432 |
| MNDR | hsa-miR-1226-3p | Pancreatic adenocarcinoma | MNDR-E-MI-05433 |
| MNDR | hsa-miR-1226-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-05434 |
| MNDR | hsa-miR-1226-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-05435 |
| MNDR | hsa-miR-1226-3p | Breast invasive carcinoma | MNDR-E-MI-05436 |
| MNDR | hsa-miR-1226-3p | Hepatocellular carcinoma | MNDR-E-MI-05437 |
| MNDR | hsa-miR-1226-3p | Malignant pleural mesothelioma | MNDR-E-MI-05438 |
| MNDR | hsa-miR-1226-3p | Skin cutaneous melanoma | MNDR-E-MI-05439 |
| MNDR | hsa-miR-1226-3p | Skin melanoma | MNDR-E-MI-05440 |
| MNDR | hsa-miR-1226-3p | Colorectal cancer | MNDR-E-MI-05441 |
| MNDR | hsa-miR-1226-3p | Nasopharynx carcinoma | MNDR-E-MI-05442 |
| MNDR | hsa-miR-1226-3p | Nasopharyngeal cancer | MNDR-E-MI-05443 |
| MNDR | hsa-miR-1226-3p | Breast cancer her3+ negative | MNDR-E-MI-05444 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CYP4Z1 | Homo sapiens | RR00387479 |
TOP